Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Motzer, Robert J; Penkov, Konstantin; Haanen, John; Rini, Brian; Albiges, Laurence; Campbell, Matthew T; Venugopal, Balaji; Kollmannsberger, Christian; Negrier, Sylvie; Uemura, Motohide; Lee, Jae L; Vasiliev, Aleksandr; Miller, Wilson H; Gurney, Howard; Schmidinger, Manuela; Larkin, James; Atkins, Michael B; Bedke, Jens; Alekseev, Boris; Wang, Jing; Mariani, Mariangela; Robbins, Paul B; Chudnovsky, Aleksander; Fowst, Camilla; Hariharan, Subramanian; Huang, Bo; di Pietro, Alessandra; Choueiri, Toni K.

N Engl J Med ; 380(12): 1103-1115, 2019 03 21.

Artículo en Inglés | MEDLINE | ID: mdl-30779531

2.

Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action.

Neilan, Tomas G; Rothenberg, Mace L; Amiri-Kordestani, Laleh; Sullivan, Ryan J; Steingart, Richard M; Gregory, William; Hariharan, Subramanian; Hammad, Tarek A; Lindenfeld, JoAnn; Murphy, Martin J; Moslehi, Javid J.

Oncologist ; 23(8): 874-878, 2018 08.

Artículo en Inglés | MEDLINE | ID: mdl-29802220

3.

Important Group Differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell Carcinoma.

Cella, David; Motzer, Robert J; Rini, Brian I; Cappelleri, Joseph C; Ramaswamy, Krishnan; Hariharan, Subramanian; Arondekar, Bhakti; Bushmakin, Andrew G.

Value Health ; 21(12): 1413-1418, 2018 12.

Artículo en Inglés | MEDLINE | ID: mdl-30502785

4.

Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.

Sternberg, Cora N; Calabrò, Fabio; Bracarda, Sergio; Cartenì, Giacomo; Lo Re, Giovanni; Ruggeri, Enzo M; Basso, Umberto; Gasparini, Giampietro; Ciuffreda, Libero; Ferrari, Vittorio; Bonetti, Andrea; Fea, Elena; Gasparro, Donatello; Tassinari, Davide; Labianca, Roberto; Masini, Cristina; Fly, Kolette; Zhang, Ke; Hariharan, Subramanian; Capaccetti, Barbara; Porta, Camillo.

Oncology ; 88(5): 273-80, 2015.

Artículo en Inglés | MEDLINE | ID: mdl-25592399

5.

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial.

Motzer, Robert J; Escudier, Bernard; Tomczak, Piotr; Hutson, Thomas E; Michaelson, M Dror; Negrier, Sylvie; Oudard, Stephane; Gore, Martin E; Tarazi, Jamal; Hariharan, Subramanian; Chen, Connie; Rosbrook, Brad; Kim, Sinil; Rini, Brian I.

Lancet Oncol ; 14(6): 552-62, 2013 May.

Artículo en Inglés | MEDLINE | ID: mdl-23598172

6.

Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.

Barrios, Carlos H; Hernandez-Barajas, David; Brown, Michael P; Lee, Se-Hoon; Fein, Luis; Liu, Jin-Hwang; Hariharan, Subramanian; Martell, Bridget A; Yuan, Jinyu; Bello, Akintunde; Wang, Zhixiao; Mundayat, Rajiv; Rha, Sun-Young.

Cancer ; 118(5): 1252-9, 2012 Mar 01.

Artículo en Inglés | MEDLINE | ID: mdl-21898376

7.

Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial.

Rini, Brian I; Moslehi, Javid J; Bonaca, Marc; Schmidinger, Manuela; Albiges, Laurence; Choueiri, Toni K; Motzer, Robert J; Atkins, Michael B; Haanen, John; Mariani, Mariangela; Wang, Jing; Hariharan, Subramanian; Larkin, James.

J Clin Oncol ; 40(17): 1929-1938, 2022 06 10.

Artículo en Inglés | MEDLINE | ID: mdl-35239416

8.

Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial.

Thomas, Stephen J; Perez, John L; Lockhart, Stephen P; Hariharan, Subramanian; Kitchin, Nicholas; Bailey, Ruth; Liau, Katherine; Lagkadinou, Eleni; Türeci, Özlem; Sahin, Ugur; Xu, Xia; Koury, Kenneth; Dychter, Samuel S; Lu, Claire; Gentile, Teresa C; Gruber, William C.

Vaccine ; 40(10): 1483-1492, 2022 03 01.

Artículo en Inglés | MEDLINE | ID: mdl-35131133

9.

Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma.

Benedict, Agnes; Figlin, Robert A; Sandström, Per; Harmenberg, Ulrika; Ullén, Anders; Charbonneau, Claudie; Sandin, Rickard; Remák, Edit; Hariharan, Subramanian; Négrier, Sylvie.

BJU Int ; 108(5): 665-72, 2011 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-21265994

10.

Non-muscle-invasive bladder cancer: An overview of potential new treatment options.

Shore, Neal D; Palou Redorta, Joan; Robert, Gregoire; Hutson, Thomas E; Cesari, Rossano; Hariharan, Subramanian; Rodríguez Faba, Óscar; Briganti, Alberto; Steinberg, Gary D.

Urol Oncol ; 39(10): 642-663, 2021 10.

Artículo en Inglés | MEDLINE | ID: mdl-34167873

11.

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.

Gore, Martin E; Szczylik, Cezary; Porta, Camillo; Bracarda, Sergio; Bjarnason, Georg A; Oudard, Stéphane; Hariharan, Subramanian; Lee, Se-Hoon; Haanen, John; Castellano, Daniel; Vrdoljak, Eduard; Schöffski, Patrick; Mainwaring, Paul; Nieto, Alejandra; Yuan, Jinyu; Bukowski, Ronald.

Lancet Oncol ; 10(8): 757-63, 2009 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-19615940

12.

Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program.

Walker, John W; Lebbé, Celeste; Grignani, Giovanni; Nathan, Paul; Dirix, Luc; Fenig, Eyal; Ascierto, Paolo Antonio; Sandhu, Shahneen; Munhoz, Rodrigo; Benincasa, Elena; Flaskett, Sarah; Reed, Josh; Engelsberg, Arne; Hariharan, Subramanian; Kasturi, Vijay.

J Immunother Cancer ; 8(1)2020 04.

Artículo en Inglés | MEDLINE | ID: mdl-32269140

13.

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial.

Motzer, Robert J; Robbins, Paul B; Powles, Thomas; Albiges, Laurence; Haanen, John B; Larkin, James; Mu, Xinmeng Jasmine; Ching, Keith A; Uemura, Motohide; Pal, Sumanta K; Alekseev, Boris; Gravis, Gwenaelle; Campbell, Matthew T; Penkov, Konstantin; Lee, Jae Lyun; Hariharan, Subramanian; Wang, Xiao; Zhang, Weidong; Wang, Jing; Chudnovsky, Aleksander; di Pietro, Alessandra; Donahue, Amber C; Choueiri, Toni K.

Nat Med ; 26(11): 1733-1741, 2020 11.

Artículo en Inglés | MEDLINE | ID: mdl-32895571

14.

Phase I trial of sunitinib malate plus interferon-alpha for patients with metastatic renal cell carcinoma.

Motzer, Robert J; Hudes, Gary; Wilding, George; Schwartz, Lawrence H; Hariharan, Subramanian; Kempin, Susan; Fayyad, Rana; Figlin, Robert A.

Clin Genitourin Cancer ; 7(1): 28-33, 2009 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-19213665

15.

Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development.

Powles, Thomas; Necchi, Andrea; Rosen, Galit; Hariharan, Subramanian; Apolo, Andrea B.

Clin Genitourin Cancer ; 16(2): 117-129, 2018 04.

Artículo en Inglés | MEDLINE | ID: mdl-29325739

16.

Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial.

Le Tourneau, Christophe; Hoimes, Christopher; Zarwan, Corrine; Wong, Deborah J; Bauer, Sebastian; Claus, Rainer; Wermke, Martin; Hariharan, Subramanian; von Heydebreck, Anja; Kasturi, Vijay; Chand, Vikram; Gulley, James L.

J Immunother Cancer ; 6(1): 111, 2018 10 22.

Artículo en Inglés | MEDLINE | ID: mdl-30348224

17.

Reply to S. Tan et al.

Rini, Brian I; Moslehi, Javid J; Hariharan, Subramanian.

J Clin Oncol ; 40(29): 3469, 2022 10 10.

Artículo en Inglés | MEDLINE | ID: mdl-35709468

18.

Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.

Schadendorf, Dirk; Lebbé, Céleste; Zur Hausen, Axel; Avril, Marie-Françoise; Hariharan, Subramanian; Bharmal, Murtuza; Becker, Jürgen C.

Eur J Cancer ; 71: 53-69, 2017 01.

Artículo en Inglés | MEDLINE | ID: mdl-27984768

19.

Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma.

Schadendorf, Dirk; Nghiem, Paul; Bhatia, Shailender; Hauschild, Axel; Saiag, Philippe; Mahnke, Lisa; Hariharan, Subramanian; Kaufman, Howard L.

Oncoimmunology ; 6(10): e1338237, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-29123950

20.

Germline Genetic Biomarkers of Sunitinib Efficacy in Advanced Renal Cell Carcinoma: Results From the RENAL EFFECT Trial.

Motzer, Robert J; Figlin, Robert A; Martini, Jean-François; Hariharan, Subramanian; Agarwal, Neeraj; Li, Chun Xiao; Williams, J Andrew; Hutson, Thomas E.

Clin Genitourin Cancer ; 15(5): 526-533, 2017 10.

Artículo en Inglés | MEDLINE | ID: mdl-28330808

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar: